Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

by Putao Cen, Eric D Tetzlaff, Jaffer A Ajani
Published 2008-03-01

Drug resistance and Cancer stem cells

by Yuan Li, Zhenning Wang, Jaffer A. Ajani, Shumei Song
Published 2021-02-01

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective

by Yan Xu, Shumei Song, Zhenning Wang, Jaffer A. Ajani
Published 2019-11-01

Review of docetaxel in the treatment of gastric cancer

by Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani
Published 2008-09-01

Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges

by Kohei Yamashita, Masaaki Iwatsuki, Jaffer A. Ajani, Hideo Baba
Published 2020-07-01

Recent advances in preoperative management of esophageal adenocarcinoma [version 1; referees: 2 approved]

by Kazuto Harada, Dilsa Mizrak Kaya, Hideo Baba, Jaffer A. Ajani
Published 2017-04-01

Customization of therapy for gastroesophageal adenocarcinoma patients

by Dilsa Mizrak Kaya, Kazuto Harada, Fatemeh G. Amlashi, Maria Vasilakopoulou, Jaffer A. Ajani
Published 2018-03-01

Recent advances in treating oesophageal cancer [version 1; peer review: 3 approved]

by Kazuto Harada, Jane E. Rogers, Masaaki Iwatsuki, Kohei Yamashita, Hideo Baba, Jaffer A. Ajani
Published 2020-10-01

Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin

by Madoka Takeuchi, Jaffer A. Ajani, Xuemin Fang, Per Pfeiffer, Masahiro Takeuchi, Hanneke W. M. van Laarhoven
Published 2019-06-01

ERCC1 and ERCC2 variants predict survival in gastric cancer patients.

by Yangkai Li, Zhensheng Liu, Hongliang Liu, Li-E Wang, Dongfeng Tan, Jaffer A Ajani, Qing-Yi Wei
Published 2013-01-01

Evolution of gastric surgery techniques and outcomes

by Hironori Shiozaki, Yusuke Shimodaira, Elena Elimova, Roopma Wadhwa, Kazuki Sudo, Kazuto Harada, Jeannelyn S. Estrella, Prajnan Das, Brian Badgwell, Jaffer A. Ajani
Published 2016-07-01

The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.

by Yu Xu, Hongxia Ma, Hongping Yu, Zhensheng Liu, Li-E Wang, Dongfeng Tan, Ramya Muddasani, Victoria Lu, Jaffer A Ajani, Yanong Wang, Qingyi Wei
Published 2013-01-01

An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.

by Jiankang Jin, Yan Xu, Longfei Huo, Lang Ma, Ailing W Scott, Melissa Pool Pizzi, Yuan Li, Ying Wang, Xiaodan Yao, Shumei Song, Jaffer A Ajani
Published 2020-01-01

Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma

by Casey J. Allen, Alisa N. Blumenthaler, Prajnan Das, Bruce D. Minsky, Mariela Blum, Sinchita Roy-Chowdhuri, Jaffer A. Ajani, Naruhiko Ikoma, Paul F. Mansfield, Brian D. Badgwell
Published 2020-02-01

Long non‐coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer

by Min‐Kyue Shin, Jungmin Kim, Dachan Kim, Sung Hwan Lee, Ji‐Hyun Shin, Yun Seong Jeong, Bo Hwa Sohn, Jimin Kim, Seong‐Ryong Kim, Jaffer A. Ajani, Ju‐Seog Lee, Jae‐Ho Cheong
Published 2021-06-01

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States

by Bradford J. Kim, Yi-Ju Chiang, Prajnan Das, Bruce D. Minsky, Mariela A. Blum, Jaffer A. Ajani, Jeannelyn S. Estrella, Wayne L. Hofstetter, Ching-Wei D. Tzeng, Brian D. Badgwell, Paul F. Mansfield, Naruhiko Ikoma
Published 2020-10-01

Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response

by Ahmed A. Abdelhakeem, Xuemei Wang, Rebecca E. Waters, Madhavi Patnana, Jeannelyn S. Estrella, Mariela Blum Murphy, Allison M. Trail, Yang Lu, Catherine E. Devine, Naruhiko Ikoma, Prajnan Das, Brian D. Badgwell, Jane E. Rogers, Jaffer A. Ajani
Published 2021-01-01

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma

by Shumei Song, Yuan Li, Yan Xu, Lang Ma, Melissa Pool Pizzi, Jiankang Jin, Ailing W Scott, Longfei Huo, Ying Wang, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Namita D Shanbhag, Randy L. Johnson, Jaffer A. Ajani
Published 2020-06-01

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma

by Yuan Li, Shumei Song, Melissa Pool Pizzi, Guangchun Han, Ailing W. Scott, Jiankang Jin, Yan Xu, Ying Wang, Longfei Huo, Lang Ma, Christopher Vellano, Xiaolin Luo, Robert MacLeod, Linghua Wang, Zhenning Wang, Jaffer A. Ajani
Published 2020-10-01

Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers

by Chan-Young Ock, Jun-Eul Hwang, Bhumsuk Keam, Sang-Bae Kim, Jae-Jun Shim, Hee-Jin Jang, Sarang Park, Bo Hwa Sohn, Minse Cha, Jaffer A. Ajani, Scott Kopetz, Keun-Wook Lee, Tae Min Kim, Dae Seog Heo, Ju-Seog Lee
Published 2017-10-01